Wound Care

Latest News

Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe
Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe

June 7th 2023

CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.

Patients With Pressure Ulcers Face Compromised Skin Parameters
Patients With Pressure Ulcers Face Compromised Skin Parameters

April 25th 2023

Electric Stimulation Found to Accelerate Chronic Wound Healing
Electric Stimulation Found to Accelerate Chronic Wound Healing

April 19th 2023

New Positive Phase 1 & 2 Results of DenovoSkin for Burns
New Positive Phase 1 & 2 Results of DenovoSkin for Burns

April 6th 2023

Latest CME Events & Activities

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Burst CME: Improving Outcomes for Your Patient with Vitiligo

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

© 2023 MJH Life Sciences

All rights reserved.